Cargando…
Development of a novel rapamycin loaded nano- into micro-formulation for treatment of lung inflammation
It has recently emerged that drugs such as the mTOR inhibitor rapamycin (Rapa) may play a key role in the treatment of airway inflammation associated with lung diseases, such as chronic obstructive pulmonary disease, asthma, and cystic fibrosis. Nevertheless, Rapa clinical application is still preve...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8857397/ https://www.ncbi.nlm.nih.gov/pubmed/35182368 http://dx.doi.org/10.1007/s13346-021-01102-5 |